New recommendations: gender -sensitive heart attack therapy for women!

Transparenz: Redaktionell erstellt und geprüft.
Veröffentlicht am

New recommendations for gender -sensitive therapy for heart attacks: Meduni Vienna presents important adjustments for women.

Neue Empfehlungen zur geschlechtersensiblen Therapie bei Herzinfarkten: MedUni Wien präsentiert wichtige Anpassungen für Frauen.
New recommendations for gender -sensitive therapy for heart attacks: Meduni Vienna presents important adjustments for women.

New recommendations: gender -sensitive heart attack therapy for women!

An international expert: Inner body has recently published new recommendations for gender -specific therapy for women with acute coronary syndrome (ACS). These recommendations created under the direction of the MedUni Vienna aim to better consider gender -specific differences in medical care. According to [VOL.AT] (https://www.vol.at/meduni-wien-praesente- Neue-Reue-Fuer-Getelmensensible-Sensible-Herzin therapy/9635312), women have a higher risk of bleeding complications in heart infarcts, which often does not adapted to non-adapted drug doses and risky access routes in catheter intervention is due.

The consensus statement was published in the "European Heart Journal" and in "Euro Intervention" and calls for an individual dosage of antithrombotic drugs, such as heparin and tile inhibitor, taking into account body weight and kidney function. This is a crucial step to optimize the therapeutic results for female patients.

Recommended measures for therapy

The recommendations also include preferred access via the radial artery on the wrist for catheter interventions. This access can help to minimize potential complications, which can be particularly important for women who suffer more often from special heart attack forms, such as myocardial infarction without significant vascular occlusion (Minoca) and spontaneous coronary arterie dessection (SCAD). A targeted, individualized antithrombotic therapy is recommended for these two forms. The routine gift of dual plaistic inhibition (DAPT) is no longer considered appropriate, as [meduniwien.ac.at] (https://www.meduniwien.at/weeb/ueber-uns/2025/news-im-juni-2025/herzinfarkt-neue-freicht-zur-glechter- therapy/).

In addition, it is pointed out to the fact that women in clinical studies on heart attack therapy are strongly underrepresented, which illustrates the need for further research efforts. These should aim to include female subjects in cardiovascular studies in order to gain sound knowledge about gender -related differences.

Important gender -specific differences

A comprehensive analysis of the gender -specific aspects cardiovascular diseases is also emphasized in a current position paper from the German Society for Cardiology (DGK). Cardiovascular diseases represent the world's leading cause of death, and there are significant differences in anatomy, etiology, symptoms and forecast between the sexes. For example, women often show different symptoms and, on average, have an elderly age and more frequent comorbidities, as from the reports of [guidelines.dgk.org] (https://leitlinien.dgk.org/2024/ sex-specific-aspekt-kardiovasculaerer diseases/).

The aim of the new recommendations and the associated research is to promote personalized treatment that includes gender -related differences in diagnostics, therapy and research. Doctors and medical staff are to be trained in order to improve the quality of care for women with cardiovascular diseases.